Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(25%)
Results Posted
100%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
3
75%
Ph phase_2
1
25%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Terminated1
Recruiting1
Suspended1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (25.0%)
N/A3 (75.0%)

Trials by Status

terminated125%
recruiting125%
suspended125%
completed125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingphase_2

NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals

NCT04055428
terminatednot_applicable

Oral Propionate to Treat and Prevent Diabetes

NCT01692002
completednot_applicable

Assessment of Liver Glucose Metabolism in Diabetic Subjects

NCT01397279
suspendednot_applicable

Insulin Sensitivity in Men With the Metabolic Syndrome

NCT00433173

Clinical Trials (4)

Showing 4 of 4 trials
NCT04055428Phase 2

NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals

Recruiting
NCT01692002Not Applicable

Oral Propionate to Treat and Prevent Diabetes

Terminated
NCT01397279Not Applicable

Assessment of Liver Glucose Metabolism in Diabetic Subjects

Completed
NCT00433173Not Applicable

Insulin Sensitivity in Men With the Metabolic Syndrome

Suspended

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4